Experts in neurology discuss changes in cognitive health and the role of sphingosine-1-phospate receptor modulators and disease-modifying therapies play in multiple sclerosis management.
EP. 1: Overview of Multiple Sclerosis
Heidi Crayton, MD; Jacqueline Nicholas, MD; and Flavia Nelson, MD, provide an overview of multiple sclerosis shedding light on the clinical course of disease.
EP. 2: Cognitive Decline Presentation in Patients With Multiple Sclerosis
Experts in neurology discuss the multiple ways in which cognitive decline can present in their patients with multiple sclerosis and highlight how they assess for it.
EP. 3: Cognitive Dysfunction Clinical Assessments for Multiple Sclerosis
Heidi Crayton, MD; Jacqueline Nicholas, MD; and Flavia Nelson, MD, share their practices and diagnostic assessments for cognitive decline in their patients with multiple sclerosis.
EP. 4: Initiating Conversations Around Cognitive Health for Patients With MS
Experts in neurology comment on the level of patient awareness surrounding cognitive decline in multiple sclerosis and highlight how to engage patients in difficult conversations regarding their cognitive health.
EP. 5: The Role of Imaging in the Assessment of Brain Health and Cognition
Heidi Crayton, MD, shares a patient story to highlight the importance of imaging modalities in identifying brain loss and atrophy in patients with multiple sclerosis [MS].
EP. 6: Brain Health Assessment Challenges in MS
Jacqueline Nicholas, MD, provides insight into challenges inherent to the assessment of brain health in patients with multiple sclerosis [MS].
EP. 7: Overview of Brain Atrophy Data and Cognition Research in MS
Flavia Nelson, MD, provides an overview of available brain atrophy data and cognition research in patients with multiple sclerosis.
EP. 8: The Role of S1P Modulators in Multiple Sclerosis Management
Dr Heidi Crayton discusses the role of S1P receptor modulators in the management of patient with multiple sclerosis.
EP. 9: Efficacy and Safety of S1P Receptor Modulators in Multiple Sclerosis
Experts in neurology review data surrounding the role of disease-modifying therapies in preventing grey matter brain atrophy and cognitive decline.
EP. 10: Impact of S1P Modulators on Brain Volume Measures in Multiple Sclerosis
Dr Flavia Nelson comments on the impact of S1P modulators on brain volume measures; highlighting thalamic atrophy and its correlation with brain volume loss in MS.
EP. 11: Safety Considerations and Monitoring for S1P Modulators in MS
Heidi Crayton, MD, and Jacqueline Nicholas, MD, review the importance of long-term safety data in the management of patients with multiple sclerosis, and Flavia Nelson, MD, discusses her approach to counseling patients on the safety considerations regarding new S1P modulating agents.
EP. 12: Using Neurofilaments as a Biomarker in MS
Dr Jacqueline Nicholas hypothesizes about the utility of neurofilaments as a biomarker of disease severity in patients with multiple sclerosis.
EP. 13: Treatment Sequencing in Patients With Multiple Sclerosis
Experts in neurology provide insight into treatment selection and sequencing in patients with multiple sclerosis, focusing on S1P modulators.
EP. 14: Emerging Therapies and Future Directions in MS
Heidi Crayton, MD; Jacqueline Nicholas, MD; and Flavia Nelson, MD, share their excitement for the future of multiple sclerosis treatment and comment on emerging therapies.
EP. 15: Practice Pearls for the Management of Multiple Sclerosis
Experts in neurology share practice pearls to optimize the treatment for patients with multiple sclerosis.
2 Clarke Drive Cranbury, NJ 08512